Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Clinical trial NCT06826339 · RECRUITING
Trial details
- NCT number
- NCT06826339
- Sponsor
- Tiger Biosciences, LLC.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2027-12-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.